Turnstone Capital
Turnstone Capital is a Connecticut-based investment firm founded in 2004 that engages in private equity and venture capital for technology-driven companies. It targets opportunities across AI infrastructure, enterprise software, energy transition technologies, and energy-efficient infrastructure, with a focus on private and emerging growth businesses. The firm pursues early-stage and expansion investments, including minority stakes with board representation, and may pursue management buyouts or acquisitions in select cases. It primarily invests in the United States but considers opportunities in the European Union, Latin America, and India. Typical deal sizes range from five to fifty million dollars, with about ten million dollars committed on average. The portfolio spans digital media, information technology, industrial technology, and financial services, reflecting a broad technology focus that supports disruptive innovation, scalable software, and sustainable energy solutions.
Top Stages
3 past transactions
Global BioDiagnostics
Series A in 2015
Global BioDiagnostics Corp. is a biotechnology company that focuses on developing and manufacturing diagnostic solutions for various diseases, particularly tuberculosis (TB). Founded in 2009 and headquartered in Temple, Texas, with an additional office in Daresbury, United Kingdom, the company specializes in creating diagnostic assays and in vivo products. These innovations facilitate the detection of active TB and support researchers in advancing TB pharmaceuticals to market. Global BioDiagnostics aims to address significant healthcare needs by providing rapid, low-cost, and user-friendly point-of-care tests for TB diagnosis.
Luxexcel
Series A in 2013
Luxexcel is a pioneering company specializing in the 3D printing of lenses and optical products. It is the only organization in the world that possesses the complete technology stack necessary for the 3D printing of optics, including hardware, software, processes, and materials. By leveraging its innovative technology, Luxexcel enables the production of custom quality prescription lenses, paving the way for advancements in both traditional eyewear and smart eyewear solutions. The company's unique 3D optic printing services are designed to create optically smooth structures and surfaces, allowing customers to obtain high-quality lenses at a reduced cost. Through its advancements, Luxexcel aims to transform the eyewear industry and support technology partners in developing specialized optical solutions.
Morgan Solar
Series A in 2010
Founded in 2007, Morgan Solar specializes in developing highly efficient, low-cost solar technology. Its flagship product, the Sun Simba HCPV, is designed for solar farm applications, while its Sun Stream Window and Sun Block Panel products cater to building applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.